(Q54302152)

27 May 2018

title

Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma. (English)

1 reference

27 May 2018

1 reference

Xiaoying Zhang

1

1 reference

27 May 2018

Hiu Ming Li

2

1 reference

27 May 2018

Zhiyan Liu

3

1 reference

27 May 2018

Gengyin Zhou

4

1 reference

27 May 2018

Qinghui Zhang

5

1 reference

27 May 2018

Tingguo Zhang

6

1 reference

27 May 2018

Jianping Zhang

7

1 reference

27 May 2018

Cuijuan Zhang

8

1 reference

27 May 2018

publication date

6 July 2012

1 reference

27 May 2018

Journal of Gastroenterology

published in

1 reference

27 May 2018

volume

48

1 reference

27 May 2018

issue

1

1 reference

27 May 2018

page(s)

132-143

1 reference

27 May 2018

Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Evaluation of the 3p21.3 tumour-suppressor gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Distinct epigenetic domains separated by a CTCF bound insulator between the tandem genes, BLU and RASSF1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Role of 5'-CpG island hypermethylation of the FHIT gene in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Frequent allelic loss on chromosome 9 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Promoter hypermethylation of resected bronchial margins: a field defect of changes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Promoter methylation of helicase-like transcription factor is associated with the early stages of gastric cancer with family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0621-0

Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal

21 January 2018

1 reference

12 December 2020

High frequency of p16INK4A gene alterations in hepatocellular carcinoma

1 reference

12 December 2020

Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma

1 reference

12 December 2020

Reciprocal relationship between methylation status and loss of heterozygosity at the p14(ARF) locus in Australian and South African hepatocellular carcinomas

1 reference

12 December 2020

Genomic instability and the selection of treatments for cancer

1 reference

12 December 2020

Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma

1 reference

12 December 2020

Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA

1 reference

12 December 2020

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

1 reference

12 December 2020

Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma

1 reference

12 December 2020

CpG hypermethylation of cellular retinol-binding protein 1 contributes to cell proliferation and migration in bladder cancer

1 reference

12 December 2020

Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas

1 reference

12 December 2020

Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer

1 reference

12 December 2020

Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China

1 reference

12 December 2020

Methylation of serum DNA is an independent prognostic marker in colorectal cancer

1 reference

12 December 2020

High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma

1 reference

12 December 2020

10.1007/S00535-012-0621-0

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018